摘要 |
<p>Use of 2H-benzimidazol-2-one, 1,3-dihydro-1-(2-ä4-Ä3-(trifluoromethyl)phenylÜ-1-piperazinylüethyl)- or a physiologically acceptable acid addition salt thereof, for the manufacture of a medicament for the treatment of extrapyramidal movement disorders. These extrapyramidal movement disorders may result from idiopathic Parkinson's disease, from the adverse effects of the administration of anti-Parkinson drugs in idiopathic Parkinson's disease, from dyskinesias caused by idiopathic Parkinson's disease and/or long-term administration of anti-Parkinson drugs, from Parkinson-like or Parkinson-related syndromes of from Parkinsonoid symptomes. Another aspect of the present invention concerns a pharmaceutical composition comprising, as active ingredients (I) 2H-benzimidazol-2-one, 1,3-dihydro-1-(2-ä4-Ä3-(trifluoromethyl)phenylÜ-1-piperazinylüethyl)- or a physiologically acceptable acid addition salt thereof, and (II) at least one anti-Parkinson drug, in combination with one or more pharmaceutically acceptable excipients.</p> |